866-997-4948 (US-Canada Toll Free)

Global Gynecological Cancers Market 2014-2018

Published By :

Technavio

Published Date : 2013-12-20

Category :

Pharmaceutical

No. of Pages : 55

Product Synopsis


TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecological Cancers market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market. 

TechNavio's report, the Global Gynecological Cancers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Gynecological Cancers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Becton Dickinson and Co., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., and GlaxoSmithKline plc.

Other vendor mentioned in the report is Merck & Co.

Key questions answered in this report: 

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table Of Content

Table of Content

1. Executive Summary

2. List of Abbreviations

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

5. Introduction

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Global Ovarian Cancers Market
6.3.1 Market Size and Forecast
6.4 Global Cervical Cancers Market
6.4.1 Market Size and Forecast
6.5 Global Uterine Cancer Market
6.5.1 Market Size and Forecast
6.6 Five Forces Analysis

7. Geographical Segmentation

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Becton, Dickinson and Co.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Bristol Myers Squibb Co.
16.2.1 Business Overview
16.2.2 Key Information
16.2.3 SWOT Analysis
16.3 Eli Lilly and Co.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis
16.4 F. Hoffmann La Roche Ltd.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.4.4 SWOT Analysis
16.5 GlaxoSmithKline plc
16.5.1 Business Overview
16.5.2 Business Segmentation
16.5.3 Key Information
16.5.4 SWOT Analysis

17. Other Reports in this Series

List of Tables

NA

List of Figures


Exhibit 1: Market Research Methodology
Exhibit 2: Global Gynecological Cancers Market 2013-2018 (US$ billion)
Exhibit 3: Global Ovarian Cancers Market 2013-2018 (US$ billion)
Exhibit 4: Global Cervical Cancers Market 2013-2018 (US$ billion)
Exhibit 5: Global Uterine Cancer Market 2013-2018 (US$ billion)
Exhibit 6: Global Gynecological Cancers Market by Geographical Segmentation 2013
Exhibit 7: Business Segmentation of Becton, Dickinson and Co.
Exhibit 8: Business Segmentation of F. Hoffmann La Roche Ltd.
Exhibit 9: Business Segmentation of GlaxoSmithKline plc.

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Febrile Neutropenia Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

    By - Transparency

    Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally, patient with febrile neutropenia is treated with prophylactic antibiotics to recover from persistent or recurrent fever...

  • Greece: apricots market

    By - Williams and Marshal Strategy

    This report presents a comprehensive overview of the apricots market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the apricots market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...

  • Cardiovascular Surgery Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018

    By - Transparency

    A shift towards minimally invasive procedures and technological advances in cardiovascular surgery devices is driving this market. This market is expected to witness double digit growth in the near future owing to the factors such as aging population and rising incidences of cardiac arrests.  Cardiac surgery is on a rise globally as cardiovascular diseases are increasing dramatically. Some of the major factors responsible for the increase in cardiovascular disease rate are increased obesity problems, poor nutrition and other heart health stress factors. Technological...